CORTI, Angelo
CORTI, Angelo
A new predictive sensor for the doxorubicin-dependent cardiotoxicity: The paradigm of chromogranin-A
2020-01-01 Rocca, C.; Granieri, M. C.; Colombo, B.; Gasparri, A. M.; Dallatomasina, A.; Pasqua, T.; De Bartolo, A.; Scavello, F.; Amelio, D.; Cerra, M. C.; Tota, B.; Corti, A.; Angelone, T.
Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells
2019-01-01 Sahu, B. S.; Mahata, S.; Bandyopadhyay, K.; Mahata, M.; Avolio, E.; Pasqua, T.; Sahu, C.; Bandyopadhyay, G. K.; Bartolomucci, A.; Webster, N. J. G.; Van Den Bogaart, G.; Fischer-Colbrie, R.; Corti, A.; Eiden, L. E.; Mahata, S. K.
Muscle injury, impaired muscle function and insulin resistance in Chromogranin a-knockout mice
2017-01-01 Tang, K; Pasqua, T; Biswas, A; Mahata, S; Tang, J; Tang, A; Bandyopadhyay, Gk; Sinha-Hikim, Ap; Chi, Nw; Webster, Nj; Corti, A; Mahata, Sk
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity
2019-01-01 Rocca, Carmine; Scavello, Francesco; Colombo, Barbara; Gasparri, Anna Maria; Dallatomasina, Alice; Granieri, Maria Concetta; Amelio, Daniela; Pasqua, Teresa; Cerra, Maria Carmela; Tota, Bruno; Corti, Angelo; Angelone, Tommaso
“Chromogranin A and uses thereof" Chromogranin A protects from doxorubicin-induced cardiotoxicity
2018-01-01 Angelone, Tommaso; Tota, B.; Corti, Angelo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A new predictive sensor for the doxorubicin-dependent cardiotoxicity: The paradigm of chromogranin-A | 1-gen-2020 | Rocca, C.; Granieri, M. C.; Colombo, B.; Gasparri, A. M.; Dallatomasina, A.; Pasqua, T.; De Bartolo, A.; Scavello, F.; Amelio, D.; Cerra, M. C.; Tota, B.; Corti, A.; Angelone, T. | |
| Catestatin regulates vesicular quanta through modulation of cholinergic and peptidergic (PACAPergic) stimulation in PC12 cells | 1-gen-2019 | Sahu, B. S.; Mahata, S.; Bandyopadhyay, K.; Mahata, M.; Avolio, E.; Pasqua, T.; Sahu, C.; Bandyopadhyay, G. K.; Bartolomucci, A.; Webster, N. J. G.; Van Den Bogaart, G.; Fischer-Colbrie, R.; Corti, A.; Eiden, L. E.; Mahata, S. K. | |
| Muscle injury, impaired muscle function and insulin resistance in Chromogranin a-knockout mice | 1-gen-2017 | Tang, K; Pasqua, T; Biswas, A; Mahata, S; Tang, J; Tang, A; Bandyopadhyay, Gk; Sinha-Hikim, Ap; Chi, Nw; Webster, Nj; Corti, A; Mahata, Sk | |
| Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity | 1-gen-2019 | Rocca, Carmine; Scavello, Francesco; Colombo, Barbara; Gasparri, Anna Maria; Dallatomasina, Alice; Granieri, Maria Concetta; Amelio, Daniela; Pasqua, Teresa; Cerra, Maria Carmela; Tota, Bruno; Corti, Angelo; Angelone, Tommaso | |
| “Chromogranin A and uses thereof" Chromogranin A protects from doxorubicin-induced cardiotoxicity | 1-gen-2018 | Angelone, Tommaso; Tota, B.; Corti, Angelo |